G1 Therapeutics (GTHX) stock forecast for 2024

The forecast has been updated: January 23, 2022 12:28


G1 Therapeutics stock price online today

Analyst Target Price

41

Dividend Date

-

Ex Dividend Date

-

Last Split Factor

Last Split Date

01.01.1970

Should you buy or sell G1 Therapeutics stock stock today? What is the projected target price level for 2024? How much will it cost in 2024? G1 Therapeutics stock Stock Monthly Prediction for January, February, March, April, May, July, July, August, September, October, November and December 2024.

We predict the dynamics of the stock market value using resonant artificial intelligence systems.

Technical, fundamental analyzes, news background, general geopolitical situation in the world and other factors are taken into account.

Forecasts are adjusted once a day taking into account the price change of the previous day.

To date, analysts have a $41 target price for G1 Therapeutics stock stock.

Today 200 Day Moving Average is the resistance level (16.67 $).

50 Day Moving Average is the resistance level (11.88 $).




GTHX Forecast for 2024

Month Rate Forecast MIN Rate MAX Rate Volati-
lity, %
Jan 9.60 8.77 11.12 21.19 %
Feb 9.57 7.81 10.60 26.32 %
Mar 9.21 8.44 9.80 13.95 %
Apr 10.15 9.36 11.85 21.05 %
May 10.43 8.71 11.33 23.11 %
Jun 8.88 7.63 9.43 19.07 %
Jul 7.75 6.35 8.74 27.31 %
Aug 6.04 4.73 7.21 34.36 %
Sep 7.01 6.33 7.56 16.28 %
Oct 6.46 5.45 7.42 26.57 %
Nov 5.73 5.19 6.15 15.60 %
Dec 6.60 5.97 7.33 18.47 %

The forecasts table above shows the forecast values of the company's stock price for each month. The Rate Forecast column displays the Optimal Average Forecast Price. The MIN Rate column displays a pessimistic forecast for this month. “MAX Rate” is an optimistic forecast. The % Volatility column represents the approximate monthly volatility of G1 Therapeutics stock.


G1 Therapeutics overview

G1 Therapeutics Address

79 T.W. ALEXANDER DRIVE, 4501 RESEARCH COMMONS, SUITE 100, RESEARCH TRIANGLE PARK, NC, US

Market Capitalization

429 898 000 $

EBITDA

-105 136 000

PE Ratio

None

PEG Ratio

0

Dividend Per Share

None

Dividend Yield

0

EPS

-3.275

Quarterly Earnings Growth YOY

0

Quarterly Revenue Growth YOY

-0.817

Trailing PE

-

Forward PE

-

EV To Revenue

6.43

EV To EBITDA

-

52 Week High

37.07

52 Week Low

9.31

50 Day Moving Average

11.88

200 Day Moving Average

16.67

Shares Outstanding

42522100

Shares Float

Shares Short Prior Month

Short Ratio

Percent Insiders

Percent Institutions

G1 Therapeutics stock forecast for this year


G1 Therapeutics stock forecast for Jan 2024.
Estimated Average Forecasted G1 Therapeutics Price: 9.60. Positive monthly dynamics of the instrument is expected with 21.194% volatility is expected.

Pessimistic forecast: 8.77

Optimistic: 11.12


G1 Therapeutics stock forecast for Feb 2024.
Estimated Average Forecasted G1 Therapeutics Price: 9.57. Negative monthly dynamics of the instrument is expected with 26.317% volatility is expected.

Pessimistic forecast: 7.81

Optimistic: 10.60


G1 Therapeutics stock forecast for Mar 2024.
Estimated Average Forecasted G1 Therapeutics Price: 9.21. Negative monthly dynamics of the instrument is expected with 13.946% volatility is expected.

Pessimistic forecast: 8.44

Optimistic: 9.80


G1 Therapeutics stock forecast for Apr 2024.
Estimated Average Forecasted G1 Therapeutics Price: 10.15. Positive monthly dynamics of the instrument is expected with 21.047% volatility is expected.

Pessimistic forecast: 9.36

Optimistic: 11.85


G1 Therapeutics stock forecast for May 2024.
Estimated Average Forecasted G1 Therapeutics Price: 10.43. Positive monthly dynamics of the instrument is expected with 23.113% volatility is expected.

Pessimistic forecast: 8.71

Optimistic: 11.33


G1 Therapeutics stock forecast for Jun 2024.
Estimated Average Forecasted G1 Therapeutics Price: 8.88. Negative monthly dynamics of the instrument is expected with 19.066% volatility is expected.

Pessimistic forecast: 7.63

Optimistic: 9.43


G1 Therapeutics stock forecast for Jul 2024.
Estimated Average Forecasted G1 Therapeutics Price: 7.75. Negative monthly dynamics of the instrument is expected with 27.314% volatility is expected.

Pessimistic forecast: 6.35

Optimistic: 8.74


G1 Therapeutics stock forecast for Aug 2024.
Estimated Average Forecasted G1 Therapeutics Price: 6.04. Negative monthly dynamics of the instrument is expected with 34.360% volatility is expected.

Pessimistic forecast: 4.73

Optimistic: 7.21


G1 Therapeutics stock forecast for Sep 2024.
Estimated Average Forecasted G1 Therapeutics Price: 7.01. Positive monthly dynamics of the instrument is expected with 16.276% volatility is expected.

Pessimistic forecast: 6.33

Optimistic: 7.56


G1 Therapeutics stock forecast for Oct 2024.
Estimated Average Forecasted G1 Therapeutics Price: 6.46. Negative monthly dynamics of the instrument is expected with 26.565% volatility is expected.

Pessimistic forecast: 5.45

Optimistic: 7.42


G1 Therapeutics stock forecast for Nov 2024.
Estimated Average Forecasted G1 Therapeutics Price: 5.73. Negative monthly dynamics of the instrument is expected with 15.603% volatility is expected.

Pessimistic forecast: 5.19

Optimistic: 6.15


G1 Therapeutics stock forecast for Dec 2024.
Estimated Average Forecasted G1 Therapeutics Price: 6.60. Positive monthly dynamics of the instrument is expected with 18.475% volatility is expected.

Pessimistic forecast: 5.97

Optimistic: 7.33



Other Healthcare sector assets

Name Symbol Last Close Price Change
Abbott Laboratories
ABT 123.82 (24.01.2022) -1.60 %
AbbVie Inc.
ABBV 131.98 (21.01.2022) -0.79 %
Aeterna Zentaris Inc.
AEZS 0.3434 (24.01.2022) 4.12 %
Allakos Inc.
ALLK 6.81 (24.01.2022) -0.58 %
Allogene Therapeutics, Inc.
ALLO 11.34 (24.01.2022) -0.18 %
Amgen Inc.
AMGN 226.08 (24.01.2022) -0.72 %
Aphria Inc.
APHA 15.38 (07.05.2021) 0.00 %
Atara Biotherapeutics, Inc.
ATRA 14.66 (24.01.2022) 4.79 %
Aurora Cannabis Inc.
ACB 4.32 (24.01.2022) -3.14 %
Becton Dickinson and Company
BDX 264.63 (21.01.2022) 0.25 %
Biogen Inc.
BIIB 220.52 (21.01.2022) -2.39 %
Biohaven Pharmaceutical Holding Company Ltd.
BHVN 110.08 (21.01.2022) -5.10 %
BioNTech SE
BNTX 150.98 (24.01.2022) 2.36 %
bluebird bio, Inc.
BLUE 7.71 (24.01.2022) 6.49 %
Boston Scientific Corp.
BSX 44.86 (14.01.2022) 0.65 %
Bristol-Myers Squibb Company
BMY 62.61 (24.01.2022) -1.46 %
Canopy Growth Corp.
CGC 7.4 (24.01.2022) 1.51 %
Castle Biosciences, Inc.
CSTL 35.44 (24.01.2022) 5.48 %
CLOVER HEALTH INVESTMENTS, CORP
CLOV 3.16 (07.01.2022) -5.67 %
Eli Lilly and Company
LLY 240.42 (24.01.2022) -1.09 %
Emergent BioSolutions Inc.
EBS 46.97 (21.01.2022) 0.97 %
Exelixis, Inc.
EXEL 18.52 (24.01.2022) 6.93 %
G1 Therapeutics, Inc.
GTHX 8.98 (24.01.2022) 2.98 %
Gilead Sciences, Inc.
GILD 68.57 (24.01.2022) 0.09 %
GlaxoSmithKline plc
GSK 44.38 (24.01.2022) -1.60 %
GoodRx Holdings, Inc.
GDRX 24.23 (24.01.2022) 3.06 %
GW Pharmaceuticals plc.
GWPH 218.96 (05.05.2021) 0.00 %
Incyte Corp.
INCY 75.34 (24.01.2022) 0.74 %
Inovio Pharmaceuticals, Inc.
INO 3.92 (24.01.2022) 0.00 %
Johnson & Johnson
JNJ 162.97 (24.01.2022) -1.15 %
Medtronic plc.
MDT 104.21 (24.01.2022) -1.32 %
Merck & Co., Inc.
MRK 78.83 (24.01.2022) -1.44 %
Moderna, Inc.
MRNA 157.3 (24.01.2022) -1.73 %
Novartis AG
NVS 85.13 (24.01.2022) -2.18 %
Novavax, Inc.
NVAX 79.47 (24.01.2022) -6.12 %
ObsEva SA
OBSV 1.5 (24.01.2022) -11.24 %
OrganiGram Holdings Inc.
OGI 1.46 (24.01.2022) 1.39 %
Pfizer Inc.
PFE 51.54 (24.01.2022) -2.37 %
Regeneron Pharmaceuticals, Inc.
REGN 621.48 (24.01.2022) 0.01 %
Sanofi
SNY 50.84 (24.01.2022) -0.78 %
Schrodinger, Inc.
SDGR 27.97 (24.01.2022) 3.29 %
Senseonics Holdings, Inc.
SENS 2.38 (24.01.2022) -8.46 %
Sorrento Therapeutics, Inc.
SRNE 3.535 (24.01.2022) -7.10 %
Stryker Corp.
SYK 251.92 (24.01.2022) -1.08 %
Sundial Growers Inc.
SNDL 0.4783 (21.01.2022) -7.74 %
Teva Pharmaceutical Industries Lim. (TEVA)
TEVA 8.46 (24.01.2022) -0.59 %
Thermo Fisher Scientific Inc.
TMO 575.8 (24.01.2022) -0.78 %
Tilray, Inc.
TLRY 5.84 (24.01.2022) 0.86 %
UnitedHealth Group, Inc.
UNH 462.27 (24.01.2022) 0.24 %
Veeva Systems Inc.
VEEV 227.36 (24.01.2022) 2.38 %
Zomedica Corp.
ZOM 0.3 (24.01.2022) -0.03 %
Zynerba Pharmaceuticals, Inc.
ZYNE 2.5 (24.01.2022) 5.49 %


Denial of responsibility:

The portal leoprophet.com is not responsible for the loss of your money as a result of your use of the information contained on the site, including data, quotes, charts and forecasts. Operations in the stock, foreign exchange and commodity markets involve a high level of risk, and you are solely responsible for your operations. Only speculate with money that you can afford to lose. All prices and forecasts for stocks, indices, futures are indicative and should not be trade dependent. The portal is not responsible for any losses that you may incur as a result of using this data.